Skip to content
LexBuild

Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed; Revocation of Approved Method; Correction

---
identifier: "/us/fr/2020-17177"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed; Revocation of Approved Method; Correction"
title_number: 0
title_name: "Federal Register"
section_number: "2020-17177"
section_name: "Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed; Revocation of Approved Method; Correction"
positive_law: false
currency: "2020-08-06"
last_updated: "2020-08-06"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2020-17177"
document_type: "notice"
publication_date: "2020-08-06"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
fr_citation: "85 FR 47798"
fr_volume: 85
docket_ids:
  - "Docket No. FDA-2020-N-0955"
fr_action: "Proposed order; correction."
---

#  Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed; Revocation of Approved Method; Correction

**AGENCY:**

Food and Drug Administration, Health and Human Services (HHS).

**ACTION:**

Proposed order; correction.

**SUMMARY:**

The Food and Drug Administration (FDA) is correcting a proposed order to revoke the approved method for detecting residues of carbadox, a carcinogenic new animal drug used in swine feed. The document was published with an incorrect docket number. This document corrects that error.

**FOR FURTHER INFORMATION CONTACT:**

Diane Heinz, Center for Veterinary Medicine (HFV-6), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 240-402-5692, *[email protected].*

**SUPPLEMENTARY INFORMATION:**

In the *Federal Register* of July 20, 2020, in FR Doc. 2020-15246, on page 43853, the following correction is made:

On page 43853, in the second column, in the header of the document, and also in the third column under *Instructions,* “Docket No. FDA-2016-N-0832” is corrected to read “Docket No. FDA-2020-N-0955”.

Dated: August 3, 2020.

Lowell J. Schiller,

Principal Associate Commissioner for Policy.